2409
Hz, 1H), 2.55 (ddd, J=4.6, 14.3, 15.5 Hz, 1H), 2.84 (ddd, J=8.5, 8.5, 15.6 Hz, 1H), 3.37 (br d, J=3.4 Hz, 1H), 3.49 (m, 1H),
3.59 (m, 1H), 3.86 (br d, J=3.1 Hz, 1H), 4.14 (m, 1H), 7.58 (m, 6H), 7.78 (m, 4H); 31P; δ 38.93; 4 (CDCl3): δ 1.65 (m, 1H),
1.84 (dddd, J=4.9, 12.6, 12.6, 12.6 Hz, 1H), 2.71 (ddd, J=5.8, 7.9, 15.3 Hz, 1H), 2.85 (ddd, J=7.9, 15.3, 15.3 Hz, 1H), 3.29
(ddd, J=2.2, 12.2, 12.2, 1H), 3.62 (m, 2H), 3.86 (m, 2H), 7.5 (m, 6H), 7.74 (m, 4H); 31P; δ 34.19; 5 (CDCl3): δ 1.83 (m,
2H), 2.63 (ddd, J=9.5, 15.0, 15.0 Hz, 1H), 2.75 (ddd, J=3.1, 9.5, 15.0 Hz, 1H), 3.46 (dd, J=3.1, 9.2 Hz, 1H), 3.58 (m, 1H),
3.67 (ddd, J=3.8, 11.6, 11.6 Hz, 1H), 3.75 (ddd, J=3.1, 9.2, 17.0 Hz, 1H), 4.12 (dd, J=3.1, 5.8 Hz, 1H), 7.5 (m, 6H), 7.72
(m, 4H); 31P; δ 34.23.
8. The importance of a phosphine oxide as the Lewis base was also confirmed from the fact that the catalysts containing a
phosphine or an amine as the Lewis base gave rather low selectivities.
9. Spectral data of ligand 7: 1H NMR (500 MHz, CDCl3); δ 1.38 (dddd, J=4.9, 12.8, 12.8, 12.8 Hz, 1H), 1.73 (m, 1H), 2.93
(s, 1H), 3.29 (m, 2H), 3.51 (m, 2H), 3.81 (dd, J=4.0, 11.6 Hz, 1H), 4.07 (dd, J=2.5, 12.5 Hz), 6.67 (s, 1H), 7.25 (m, 6H),
7.53 (m, 7H), 7.94 (m, 2H): 31P NMR (202.35 MHz, CDCl3); δ 38.29: 13C NMR (125.65 MHz, CDCl3); δ 31.68, 51.53 (d,
J=66 Hz), 65.86, 71.62, 73.51, 78.37 (d, J=6 Hz), 127.56, 128.26, 128.30, 128.39, 129.02, 129.11, 129.88, 130.65, 130.72,
18
130.97, 131.04, 131.07, 131.14, 131.46, 131.52, 131.70 (d), 131.82 (d), 132.23 (d): [α]D +14.1 (c=0.55, CHCl3).
10. The stereochemistry of the substituent was determined from the coupling constant of 1H NMR as shown below.
11. Effects of other substituents: β-Me (58% ee (S)), α-Me (23% ee (S)), β-Bu (56% ee (S)), α-Bu (47% ee (S)), β-iPr (37%
ee (S)) α-iPr (32% ee (R)).
12. Representative procedures: To a solution of the ligand (0.0245 mmol) in CH2Cl2 (0.4 mL) was added Et2AlCl (0.0238
mmol as a 0.95 M hexane solution) at ambient temperature under Ar atmosphere. After stirring for 2 h, the reaction mixture
was cooled to −78°C and the aldehyde (0.48 mmol) was added. After 30 min, TMSCN (0.58 mmol) was added in one
portion and the mixture was stirred at −60°C until the starting aldehyde disappeared on TLC (SiO2, AcOEt/hexane 1/4).
Acid hydrolysis and usual workup followed by purification by silica gel column chromatography gave the corresponding
cyanohydrin.
13. These calculations were done with the universal force field of Cerius 2_3.8.
14. From the Curtin–Hammet principle, the distribution of the ground state species may not be reflected on the actual reaction
pathway. However, the difference between transition state energies by the dual activation pathway and the mono activation
pathway by the Lewis acid seems to be not large enough to overcome the ground state distribution, since the activation of
TMSCN by the phosphine oxide is not strong. For the activation ability of the phosphine oxide toward TMSCN, see Ref. 1.
15. The same consideration may explain the lower enantioselectivities by α-substituted catalysts (see Ref. 11). In these cases,
the optimum conformer A is destabilized by the α-substituent.
16. However, the cyanosilylation of acetophenone with catalyst 1 did not proceed.
17. The ee of the TMS protected cyanohydrin was determined by chiral HPLC column (Chiralcel OJ, iPrOH/hexane 2/98, flow
rate 0.5 mL/min, retention time 15 min for the R isomer and 16 min for the S isomer). The absolute configuration of the
product was determined by the optical rotation of the cyanohydrin: Kilijunen, E.; Kanerva, L. T. Tetrahedron: Asymmetry
1997, 8, 1551–1557. Compound 7 gave the almost the same ee.